Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell.
When used as drugs, the International Nonproprietary Names (INNs) end in -mab.
The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies.
The abbreviations in the column Type are as follows: This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage.
Immune activation: Dostarlimab Other: Ibalizumab